PROSAN Tablet

ក្រុមហ៊ុនផលិតឱសថ:

 

BEXIMCO PHARMACEUTICALS LTD., Bangladesh

  • សារធាតុសកម្ម
  • ប្រសិទ្ធិភាពព្យាបាល និង កម្រិតប្រើប្រាស់
  • ហាមប្រើ
  • ផលរំខាន
  • អន្តរប្រតិកម្ម
  • ស្ត្រីមានផ្ទៃពោះ និង ស្ត្រីបំបៅដោះកូន
  • ការប្រុងប្រយ័ត្នជាពិសេស
  • សកម្មភាពឱសថ
  • បរិយាយប័ណ្ណឱសថ 
  • សារធាតុសកម្ម

    1. PROSAN 25 Tablet:

    Losartan potassium 25mg

    2. PROSAN 50 Tablet:

    Losartan potassium 50mg

  • ប្រសិទ្ធិភាពព្យាបាល និង កម្រិតប្រើប្រាស់

    It is indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.

    Dosage and Administration

    The usual starting dose is 50mg once daily, with 25mg used in patients with possible depletion of intravascular volume (e.g., patients treated with diuretics) and patients with a history of hepatic impairment. It can be administered once or twice daily with total daily doses ranging from 25mg to 100mg.

  • ហាមប្រើ

    Losartan Potassium is contraindicated in patients who are hypersensitive to the active ingredient or any component of the drug.

  • ផលរំខាន

    In clinical trials, dizziness was the only side effect reported that occurred with an incidence greater than placebo in 1% patients treated with Losartan. Rarely, rash was reported, although the incidence in controlled clinical trials was less than placebo. Angioedema, involving swelling of the face, lips and/or tongue, has been reported rarely in patients treated with Losartan. The incidence of cough is similar to placebo and significantly lower than that observed with ACE inhibitors.

  • អន្តរប្រតិកម្ម

    No drug interactions of clinical significance have been identified. Compounds that have been studied in clinical pharmacokinetic trials include hydrochlorothiazide, digoxin, warfarin, cimetidine, ketoconazole, and phenobarbital.

  • ស្ត្រីមានផ្ទៃពោះ និង ស្ត្រីបំបៅដោះកូន

    Pregnant women

    Prosan must be discontinued as soon as possible when pregnancy is detected.

    Lactation

    It should not be prescribed during lactation, as there is no information in human on the passage of Losartan into breast milk.

  • ការប្រុងប្រយ័ត្នជាពិសេស

    Children: There are no data on the safety or efficacy of Prosan in children.

  • សកម្មភាពឱសថ

    Losartan Potassium is an angiotensin-Ⅱreceptor (type AT1) antagonist. Angiotensin-Ⅱis a potent vasoconstrictor, the primary vasoactive hormone of the renin-angiotensin system and an important component in the pathophysiology of hypertension. Losartan and its principal active metabolite block the vasoconstrictor and aldosterone secreting effects of angiotensin-Ⅱby selectively blocking the binding of angiotensin-Ⅱto the AT1 receptor found in many tissues

*ព័ត៌មានឱសថត្រូវបានរៀបរៀងដោយ អ៊ីម៉ាតុគឹ មេឌីក (ខេមបូឌា) ដោយផ្អែកលើប្រភពព័ត៌មានខាងក្រោម។ សម្រាប់ព័ត៌មានលម្អិត សូមស្វែងរកនៅក្នុងក្រដាសព័ត៌មាននៃឱសថនីមួយៗ ឬ សាកសួរទៅកាន់ក្រុមហ៊ុនឱសថឬតំណាងចែកចាយនៃឱសថនីមួយៗ។

ប្រភពព័ត៌មាន៖

- ក្រដាសព័ត៌មាននៃឱសថសម្រាប់អ្នកជំនាញវេជ្ជសាស្ត្រដែលប្រើប្រាស់នៅប្រទេសជប៉ុន (Pharmaceutical and Medical Devices Agency, Pmda): https://www.pmda.go.jp

- ព័ត៌មានសង្ខេបនៃឱសថសម្រាប់អ្នកជំងឺដែលប្រើប្រាស់នៅប្រទេសជប៉ុន: http://www.rad-ar.or.jp